Integragen Net Income From Continuing Ops from 2010 to 2026
| ALINT Stock | EUR 0.18 0.01 5.88% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -197.1 K | Current Value -207 K | Quarterly Volatility 995 K |
Check Integragen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integragen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 96.8 K, Interest Expense of 4.2 K or Selling General Administrative of 3.1 M, as well as many indicators such as Price To Sales Ratio of 0.48, Dividend Yield of 0.0 or PTB Ratio of 2.37. Integragen financial statements analysis is a perfect complement when working with Integragen Valuation or Volatility modules.
Integragen | Net Income From Continuing Ops |
Evaluating Integragen's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Integragen's fundamental strength.
Latest Integragen's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Integragen over the last few years. It is Integragen's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Integragen's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Integragen Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (1,047,486) | |
| Geometric Mean | 436,360 | |
| Coefficient Of Variation | (94.99) | |
| Mean Deviation | 844,031 | |
| Median | (862,172) | |
| Standard Deviation | 994,956 | |
| Sample Variance | 989.9B | |
| Range | 2.6M | |
| R-Value | 0.91 | |
| Mean Square Error | 180.4B | |
| R-Squared | 0.83 | |
| Slope | 179,417 | |
| Total Sum of Squares | 15.8T |
Integragen Net Income From Continuing Ops History
About Integragen Financial Statements
Integragen shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Integragen investors may analyze each financial statement separately, they are all interrelated. The changes in Integragen's assets and liabilities, for example, are also reflected in the revenues and expenses on on Integragen's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -197.1 K | -207 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Integragen Stock Analysis
When running Integragen's price analysis, check to measure Integragen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integragen is operating at the current time. Most of Integragen's value examination focuses on studying past and present price action to predict the probability of Integragen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integragen's price. Additionally, you may evaluate how the addition of Integragen to your portfolios can decrease your overall portfolio volatility.